Synektik Spólka Akcyjna (WSE:SNT)

Market Cap	2.57B +33.5%
Revenue (ttm)	794.94M +34.1%
Net Income	386.70M +364.7%
EPS	45.34 +364.7%
Shares Out	8.53M
PE Ratio	16.24
Forward PE	16.55
Dividend	10.75 (3.57%)
Ex-Dividend Date	Apr 2, 2026

Volume	41,172
Open	300.80
Previous Close	300.80
Day's Range	300.80 - 314.00
52-Week Range	180.20 - 317.00
Beta	0.54
Analysts	Strong Buy
Price Target	315.46 (+2.03%)
Earnings Date	Jun 11, 2026

About Synektik Spólka Akcyjna

Synektik Spólka Akcyjna provides products, services, and IT solutions for surgery, diagnostic imaging, and nuclear medicine applications in Poland. The company sells medical equipment used in diagnostics and therapy, and nuclear medicine. It is also involved in development of IT solutions used in radiology, as well as research, produces, and sells radiopharmaceutical products used in diagnostics for oncology. In addition, the company operates a research laboratory for diagnostic imaging systems and a service center for medical equipment. Furthe...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2001
• Employees: 231
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: SNT

Financial Performance

In fiscal year 2025, Synektik Spólka Akcyjna's revenue was 681.60 million, an increase of 9.21% compared to the previous year's 624.12 million. Earnings were 102.93 million, an increase of 24.66%.

Analyst Summary

According to 5 analysts, the average rating for SNT stock is "Strong Buy." The 12-month stock price target is zł 315.46, which is an increase of 2.03% from the latest price.

Price Target

zł 315.46

(2.03% upside)

Analyst Consensus: Strong Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jun 16, 2026

Data Sources Report a data error